Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of British Columbia

$31,000.00

Cheminformatics modelling and discovery of peptide-based antibiotics active against drug resistant bacteria

FY 2015-16

Summary
Worldwide, infectious diseases are the leading cause of premature mortality. In Canada they are the fifth leading cause of premature loss of life and a major cause of lost economic productivity. Moreover, the rise of antibiotic resistant microorganisms, hospital-acquired infections, and emergence and re-emergence of new infectious threats such as Avian influenza A, Lyme disease, West Nile virus, Hantavirus pulmonary syndrome, Norwalk-like virus, HIV, SARS, novel forms of Cryptococcal infection, drug resistant Staphylococcus aureus and Mycobacterium tuberculosis amongst others, make the situation even more critical. The research proposal is focused on the development of computational models for antimicrobials and discovery of novel peptide-based antibiotics. It is build upon novel cheminformatics approaches developed in my laboratory and our pioneering work in the area of QSAR (quantitative structure-activity relationships) modeling of antimicrobial peptides. The previous history of successful application of QSAR models have already demonstrated their adequately and sufficiency for describing antimicrobial activity of small molecules and peptides. Thus, the proposed research aims at: a) expanding the range and scope of QSAR descriptors and solutions suitable for modeling antimicrobial activity and developing more accurate and more interpretable QSAR solutions that can be readily utilized for discovering and improving peptide-based antibiotics; b) establishing a large-scale iterative pipeline consisting of computational component for designing antimicrobial peptide candidates and experimental part of high-throughput synthesis and screening of the peptides.
Program
Discovery Grants Program - Individual
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
288172-2011
Name nom
Cherkasov, Artem
Department département
Medicine, Department of
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2011
Award amount
31000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
6400
Research subject group en
Life sciences research related to human health and disease
Research subject group fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Research subject en
Life sciences research related to human health and disease
Research subject fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Partie
5
Nb partie
5
Application title
Cheminformatics modelling and discovery of peptide-based antibiotics active against drug resistant bacteria
Keyword
NSERC
Application summary
Worldwide, infectious diseases are the leading cause of premature mortality. In Canada they are the fifth leading cause of premature loss of life and a major cause of lost economic productivity. Moreover, the rise of antibiotic resistant microorganisms, hospital-acquired infections, and emergence and re-emergence of new infectious threats such as Avian influenza A, Lyme disease, West Nile virus, Hantavirus pulmonary syndrome, Norwalk-like virus, HIV, SARS, novel forms of Cryptococcal infection, drug resistant Staphylococcus aureus and Mycobacterium tuberculosis amongst others, make the situation even more critical. The research proposal is focused on the development of computational models for antimicrobials and discovery of novel peptide-based antibiotics. It is build upon novel cheminformatics approaches developed in my laboratory and our pioneering work in the area of QSAR (quantitative structure-activity relationships) modeling of antimicrobial peptides. The previous history of successful application of QSAR models have already demonstrated their adequately and sufficiency for describing antimicrobial activity of small molecules and peptides. Thus, the proposed research aims at: a) expanding the range and scope of QSAR descriptors and solutions suitable for modeling antimicrobial activity and developing more accurate and more interpretable QSAR solutions that can be readily utilized for discovering and improving peptide-based antibiotics; b) establishing a large-scale iterative pipeline consisting of computational component for designing antimicrobial peptide candidates and experimental part of high-throughput synthesis and screening of the peptides.